WASHINGTON -- The Federal Drug Administration missed opportunities to protect victims of a deadly meningitis outbreak, according to a new report by staff of the House Energy and Commerce Oversight and Investigations Subcommittee.
The FDA missed numerous warning signs at the New England Compounding Center, the pharmacy that distributed contaminated drugs that led to an outbreak that killed 53 patients and sickened many others, according to the report.
Subcommittee chairman Tim Murphy, R-Upper St. Clair, said his staff reviewed 27,000 documents and found that patients, providers and whistleblowers had been warning the FDA about problems for years.
More than 700 people received the injections from healthcare providers.
The report, which was announced by Mr. Murphy's office today, is available online at www.energycommerce.house.gov.
Tracie Mauriello: firstname.lastname@example.org